Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Comparative Efficacy of Incretin-Based Therapies After ~48 Weeks This bar chart presents a direct comparison between Mazdutide 6 mg, Tirzepatide 15 mg, Semaglutide 2.4 mg, and Placebo across three key anthropometric outcomes: Percentage Weight Loss Tirzepatide: 15.0% Mazdutide: 14.0% Semaglutide: 12.4% Placebo: +0.3% Patients Achieving 15% Weight Loss Tirzepatide: 51.0% Mazdutide: 49.5% Semaglutide: 36.0% Placebo: 2.0% Reduction in Waist Circumference (cm) Mazdutide: 10.7 cm Tirzepatide: 9.5 cm Semaglutide: 8.5 cm Placebo: 1.4 cm Interpretation Mazdutide demonstrates comparable efficacy to tirzepatide in both absolute weight reduction and waist circumference improvement, outperforming semaglutide across these endpoints
J Neurochem 97(Suppl 1):148153
et al Combinations of common polymorphisms within GSTA1 and GSTT1 as a risk factor for psoriasis in a Central European population: a case-control study
This gene-regulatory profile has made GHK-Cu skin research a particularly active field
PMCID: PMC9917998
This product is sold strictly for laboratory research purposes only
